DGAP-News: Oxford Immunotec / Oxford Immunotec Schedules Fourth Quarter and Full Year 2013 Earnings Release and Conference Call for March 4, 2014 24.02.2014 / 19:41 --------------------------------------------------------------------- OXFORD, United Kingdom and MARLBOROUGH, Mass., 2014-02-24 19:41 CET (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) today announced that it plans to release fourth quarter and full year 2013 financial results prior to market open on Tuesday, March 4, 2014. Dr. Peter Wrighton-Smith, Chief Executive Officer and Rick Altieri, Chief Financial Officer will host a conference call to review the Company's results at 8:00am Eastern Time the same day. The call will be concurrently webcast. To listen to the conference call on your telephone, please dial (855) 363-5047 for United States callers and +1 (484) 365-2897 for international callers and reference confirmation code 2444858, approximately ten minutes prior to start time. To access the live audio webcast or subsequent archived recording, visit the Investor Relations section of Oxford Immunotec's website at http://www.oxfordimmunotec.com. The replay will be available on the Company's website for approximately 90 days. Notes to Editors: About Oxford Immunotec Oxford Immunotec Global PLC is a global, commercial-stage diagnostics company committed to improving patient care by providing advanced, innovative tests in the field of immunology. The proprietary T-SPOT(r) technology platform measures the responses of specific immune cells, known as T cells, to inform the diagnosis, prognosis and monitoring of patients with immunologically controlled diseases. T cells are a central component of the human body's immune system, and are implicated in the control and progression of many medical conditions, including certain types of infectious diseases, cancers and autoimmune diseases. The Company's initial product developed using the T-SPOT technology platform is the T-SPOT.TB test, which is used to test for latent tuberculosis infection. The T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The Company is headquartered near Oxford, UK and in Marlborough, MA. Additional information can be found at www.oxfordimmunotec.com. T-SPOT and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd. CONTACTS: For Media Inquiries: Caroline Crawley Oxford Immunotec Tel: +44 1235 442796 ccrawley@oxfordimmunotec.com For Investor Inquiries: Rick Altieri Chief Financial Officer, Oxford Immunotec Tel: +1 (508) 481-4648 raltieri@oxfordimmunotec.com Mark Klausner Westwicke Partners Tel: +1 (443) 213-0500 oxfordimmunotec@westwicke.com News Source: NASDAQ OMX End of Corporate News --------------------------------------------------------------------- 24.02.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Oxford Immunotec United Kingdom ISIN: GB00BGFBB958 End of News DGAP News-Service --------------------------------------------------------------------- 254060 24.02.2014
DGAP-News: Oxford Immunotec Schedules Fourth Quarter and
Top 10 Most Recent News Articles
Frontera Energy's Q3 Results Call: Key Insights Ahead
What to Expect from Frontera’s Upcoming Call Frontera Energy’s got a date with the earnings table, and it’s set for November 11. The story here is about anticipation, folks. This Canadian energy player will lay its third-quarter results bare soon as trading wraps up. They’ll be breaking the nitty-gritty down in a call with the analysts that follows the next day,...
Continue Reading
Hanwha's Big Bet: Tokenizing Real-World Assets with Chainlink
Hanwha and Chainlink: A Game Changer in Tokenization What do Hanwha Investment & Securities, a heavyweight in Korea's finance scene, and Chainlink, the wizard of onchain finance, think they're up to? They're buddies now, locked and loaded, to tokenize real-world assets (RWAs). They're not just shaking hands; they're aiming to jiggle the global finance bedrock....
Continue Reading
W.E.B. Du Bois Documentary Ignites Voting Rights Discussion
The Lasting Resonance of W.E.B. Du Bois When we think about the fight for democracy, the legacy of W.E.B. Du Bois is bound to pop up. Thanks to director Rita Coburn, his legacy gets a full-on showcase through her latest documentary, W.E.B. Du Bois: Rebel With a Cause. This piece isn't just about looking back—it's about turning history into a mirror reflecting today's...
Continue Reading
Human Judgment Crucial Amid AI Growth in Courts
AI in the Justice System: Balancing Potential and Pitfalls You know, when it comes to upholding justice, there's a line between what machines can handle and what only a human can bring to the gavel. Chief Justice Sundaresh Menon of Singapore threw the spotlight on this at an event in Brisbane, hammering home the need for good ole human intuition in the courtroom even as...
Continue Reading
FDA Greenlights VELO: A Turning Point for Reynolds?
FDA Decision: A Big Win for Reynolds American Boy, am I seeing a shift in the winds. The FDA's green light for VELO nicotine pouches adds a fresh feather to Reynolds American's cap. In a gritty industry like tobacco, getting FDA's nod ain't just about safety; it’s a strategic leg up against traditional smoke. My gut tells me this isn't just about keeping pace. It's...
Continue Reading
Food Emulsifiers Surge: Market to Hit $5.60B by 2031
Forecasting Growth in Food Emulsifiers Picture this: the food emulsifiers market is steaming ahead, anticipating a thunderous boom from $4.43 billion in 2026 to a whopping $5.60 billion by 2031. According to recent estimates, that's a steady clip at a CAGR of 4.8%. If you're thinking that's just more industry chatter, let's peel back the layers and see what makes this...
Continue Reading
Novelis Readies for Q2 Earnings Amid Global Market Focus
Amid the ever-turbulent waves of industrial demand and environmental expectations, Novelis Inc. is set to lay bare its fiscal cards for Q2 of 2027. Circle November 5 on your calendar—this is when Steve Fisher and Dev Ahuja aim to sift through the heaps, scrutinize numbers, and spell out their game plan for investors via a conference call. Get your coffee ready for this...
Continue Reading
AbbVie's Q3 2026: Strong Performance and Bold Moves
A Deep Dive into AbbVie's Q3 2026 Numbers Bruised and battered from the ebbs and flows of the market, AbbVie (NYSE:ABBV) decided to show up in swagger mode for the third quarter of 2026. They doubled their diluted EPS year over year with a GAAP figure hitting $2.37, backed by an adjusted EPS of $3.82. You're seeing the fruits of savvy expansions and a portfolio that seems...
Continue Reading
Triskell's 2026 Update: AI Leverages Portfolio Data
Triskell's Strategic AI Leap Forward Forget the old grind of manual data tinkering—Triskell Software's latest AI enhancements in their 2026 SP2 release are setting a new stage. The Spain-based outfit is tweaking their Project Portfolio Management tools under the hood to suit modern instincts. It seems like portfolio management is getting a brain boost with some added AI...
Continue Reading
Cohen Veterans Network Invites Americans to Honor Veterans
Cohen Veterans Network Launches "Call to Honor" Initiative The struggle to adequately acknowledge the sacrifices of veterans isn't new, but Cohen Veterans Network (CVN) is trying something a little different this time. "Call to Honor," a gratitude hotline, isn't just another method of saying "thanks"—it's a more profound communication channel for Americans to express...
Continue ReadingTop 5 Most Recently Viewed Articles
Jack Dorsey Calls Tesla's Cybertruck the Ultimate Machine
Jack Dorsey Hails the Cybertruck as a Superior Electric Vehicle Recently, Block Inc. CEO and Twitter co-founder Jack Dorsey expressed admiration for Tesla Inc.'s innovation by referring to the Cybertruck as "the best robot out there." This comment resonates with the growing anticipation surrounding Tesla's electric utility truck, which stands out for its advanced...
Continue Reading
Planview Enhances Software Delivery with Plutora Acquisition
Planview's Strategic Acquisition of Plutora Planview has made a major move by acquiring Plutora, a step aimed at enriching its product offerings. As a leader in Strategic Portfolio Management (SPM) and Digital Product Development (DPD), Planview is eager to harness Plutora's advanced Value Stream Management (VSM) solutions to bring great value to its customers. Reasons...
Continue Reading
SoFi Innovates Payments with Galileo's Cyberbank Core Technology
SoFi Technologies Transforming Payment Services SoFi Technologies, Inc. (NASDAQ: SOFI) has recently announced a significant upgrade to its payment service offerings by adopting Galileo’s advanced cloud-based Cyberbank Core. This powerful technology is set to enhance a variety of payment solutions, including debit, prepaid, ACH, and wire transactions for its commercial...
Continue Reading
Top Financial Headlines: Key Insights from September 2025
Key Financial Developments: A September Recap September proved to be a pivotal month in the finance sector, showcasing a variety of noteworthy press releases. This recap focuses on significant developments that shaped the industry, highlighting major mergers, innovative funding strategies, and the ongoing transformation fueled by AI technology. Major Mergers and...
Continue Reading
Lerøy Seafood Group ASA Announces Ex-Dividend Information Today
Ex-Dividend Announcement for Lerøy Seafood Group ASA Lerøy Seafood Group ASA has officially announced that its shares will trade ex-dividend today, meaning that shareholders will receive NOK 2.50 per share. This adjustment marks an important date for investors looking to benefit from this dividend. Understanding Ex-Dividend Dates It's crucial for investors to grasp the...
Continue Reading